aTyr Pharma reported $2.84M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Ardelyx USD 157.56M 18.57M Sep/2026
aTyr Pharma USD 2.84M 45.19K Jun/2026
Biogen USD 2.22B 159.9M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Cipla INR 67.78B 1.82B Sep/2026
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
GlaxoSmithKline GBP 6.28B 125M Jun/2026
Grifols EUR 3.56B 63.19M Dec/2024
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Novartis USD 6.1B 116M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025
United Therapeutics USD 201.9M 8.1M Sep/2026